About
Alcolase is a Danish biotech startup developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream. This technology is specifically aimed at individuals with ALDH2 deficiency, a genetic variant common in East Asia that impairs alcohol metabolism, leading to adverse reactions and increased health risks. The company's proprietary encapsulation technology protects enzymes from stomach acid, allowing them to remain active in the stomach. Alcolase plans to initially target markets in Singapore and South Korea, with a long-term vision of creating healthier alternatives within global drinking culture and exploring broader therapeutic use-cases through its UK subsidiary.
Tags
Total Employees
8
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Alcolase do?
Alcolase is a Danish biotech startup developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream. This technology is specifically aimed at individuals with ALDH2 deficiency, a genetic variant common in East Asia that impairs alcohol metabolism, leading to adverse reactions and increased health risks. The company's proprietary encapsulation technology protects enzymes from stomach acid, allowing them to remain active in the stomac…
How much funding has Alcolase raised?
Alcolase has raised a total of $14.9B in funding. The most recent round on record is Seed.
Where is Alcolase headquartered?
Alcolase is headquartered in Copenhagen, Denmark.
When was Alcolase founded?
Alcolase was founded in 2021.
What industry does Alcolase operate in?
Alcolase operates in Biotechnology, Health, Pharmaceuticals, Drug Delivery, Biotech, HealthTech.
How many employees does Alcolase have?
Alcolase has approximately 8 people on record.